Form 4 for ATLX Atlas Lithium Corp
Accepted 2023-12-29 00:00:00 ET · period of report 2023-12-21 · accession 0001493152-23-046637 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-12-29 | 2023-12-22 | ATLX | Fogassa Marc | CEO, Dir, 10% | C - Cnv Deriv | — | +1.20M | 4.34M | +38% | — |
| D | 2023-12-29 | 2023-12-21 | ATLX | Fogassa Marc | CEO, Dir, 10% | X - OptEx | $0.01 | +151.1K | 3.14M | +5% | +$1,511 |
| DM | 2023-12-29 | 2023-12-21+ | ATLX | Fogassa Marc | CEO, Dir, 10% | X - OptEx | $0.0436 | -151.1K | 90.0K | -63% | -$6,588 |
| D | 2023-12-29 | 2023-12-22 | ATLX | Fogassa Marc | CEO, Dir, 10% | C - Cnv Deriv | — | -90.0K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-22 | C | A | 1,199,997 | — | 4,338,686 | D | — | — | (F1) The shares of Common Stock were acquired on conversion of shares of Series D Convertible Preferred Stock ("Series D Preferred"). |
| 2 | Common | Common Stock | 2023-12-21 | X | A | 151,141 | $0.01 | 3,138,689 | D | — | — | |
| 3 | Derivative | Series D Convertible Preferred Stock Options | 2023-12-22 | X | D | 90,000 | $0.1 | 0 | D | $0.1 · — to — | 90,000 Series D Preferred Stock | (F5) Following the transactions described in this Statement, the Reporting Person has no Series D Options. (F4) The Series D Convertible Preferred Stock Options (the "Series D Options") were earned by the reporting person on a monthly basis between January 1, 2021 and December 1, 2023 as previously reported on Forms 4, and were immediately exercisable on the date of grant. The Series D Options had expiration dates between December 31, 2030 and November 30, 2033. |
| 4 | Derivative | Common Stock Option | 2023-12-21 | X | D | 151,141 | $0.01 | 0 | D | $0.01 · 2019-04-17 to 2024-02-19 | 151,141 Common Stock | (F3) Following the transactions described in this Statement, the Reporting Person has no Common Stock Options. |
| 5 | Derivative | Series D Convertible Preferred Stock | 2023-12-22 | X | A | 90,000 | — | 90,000 | D | — · — to — | 1,199,997 Common Stock | (F6) Each share of Series D Preferred Stock was convertible at any time, at the election of the holder, into 13 1/3 shares of Common Stock. The Series D Preferred had no expiration date. (F4) The Series D Convertible Preferred Stock Options (the "Series D Options") were earned by the reporting person on a monthly basis between January 1, 2021 and December 1, 2023 as previously reported on Forms 4, and were immediately exercisable on the date of grant. The Series D Options had expiration dates between December 31, 2030 and November 30, 2033. |
| 6 | Derivative | Series D Convertible Preferred Stock | 2023-12-22 | C | D | 90,000 | — | 0 | D | — · — to — | 1,199,997 Common Stock | (F6) Each share of Series D Preferred Stock was convertible at any time, at the election of the holder, into 13 1/3 shares of Common Stock. The Series D Preferred had no expiration date. (F7) Following the transactions described in this Statement, the Reporting Person has no Series D Preferred. (F4) The Series D Convertible Preferred Stock Options (the "Series D Options") were earned by the reporting person on a monthly basis between January 1, 2021 and December 1, 2023 as previously reported on Forms 4, and were immediately exercisable on the date of grant. The Series D Options had expiration dates between December 31, 2030 and November 30, 2033. |